Literature DB >> 29292371

Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease.

Stephen R Holdsworth1, A Richard Kitching1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29292371     DOI: 10.1038/nrneph.2017.171

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity.

Authors:  R G Phelps; A J Rees
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

2.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

3.  C5a receptor (CD88) blockade protects against MPO-ANCA GN.

Authors:  Hong Xiao; Daniel J Dairaghi; Jay P Powers; Linda S Ertl; Trageen Baumgart; Yu Wang; Lisa C Seitz; Mark E T Penfold; Lin Gan; Peiqi Hu; Bao Lu; Norma P Gerard; Craig Gerard; Thomas J Schall; Juan C Jaen; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

4.  Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Authors:  Bengt C Fellström; Jonathan Barratt; Heather Cook; Rosanna Coppo; John Feehally; Johan W de Fijter; Jürgen Floege; Gerd Hetzel; Alan G Jardine; Francesco Locatelli; Bart D Maes; Alex Mercer; Fernanda Ortiz; Manuel Praga; Søren S Sørensen; Vladimir Tesar; Lucia Del Vecchio
Journal:  Lancet       Date:  2017-03-28       Impact factor: 79.321

5.  Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.

Authors:  Joshua D Ooi; Jan Petersen; Yu H Tan; Megan Huynh; Zoe J Willett; Sri H Ramarathinam; Peter J Eggenhuizen; Khai L Loh; Katherine A Watson; Poh Y Gan; Maliha A Alikhan; Nadine L Dudek; Andreas Handel; Billy G Hudson; Lars Fugger; David A Power; Stephen G Holt; P Toby Coates; Jon W Gregersen; Anthony W Purcell; Stephen R Holdsworth; Nicole L La Gruta; Hugh H Reid; Jamie Rossjohn; A Richard Kitching
Journal:  Nature       Date:  2017-05-03       Impact factor: 49.962

6.  Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.

Authors:  Britta E Jones; Jiajin Yang; Akhil Muthigi; Susan L Hogan; Yichun Hu; Joshua Starmer; Candace D Henderson; Caroline J Poulton; Elizabeth J Brant; William F Pendergraft; J Charles Jennette; Ronald J Falk; Dominic J Ciavatta
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

7.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.

Authors:  Jia Jin Yang; William F Pendergraft; David A Alcorta; Patrick H Nachman; Susan L Hogan; Robin P Thomas; Pamela Sullivan; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 8.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

9.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

10.  Genetically distinct subsets within ANCA-associated vasculitis.

Authors:  Paul A Lyons; Tim F Rayner; Sapna Trivedi; Julia U Holle; Richard A Watts; David R W Jayne; Bo Baslund; Paul Brenchley; Annette Bruchfeld; Afzal N Chaudhry; Jan Willem Cohen Tervaert; Panos Deloukas; Conleth Feighery; Wolfgang L Gross; Loic Guillevin; Iva Gunnarsson; Lorraine Harper; Zdenka Hrušková; Mark A Little; Davide Martorana; Thomas Neumann; Sophie Ohlsson; Sandosh Padmanabhan; Charles D Pusey; Alan D Salama; Jan-Stephan F Sanders; Caroline O Savage; Mårten Segelmark; Coen A Stegeman; Vladimir Tesař; Augusto Vaglio; Stefan Wieczorek; Benjamin Wilde; Jochen Zwerina; Andrew J Rees; David G Clayton; Kenneth G C Smith
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

  10 in total
  4 in total

1.  Efficacy of Glucocorticoids and Glucocorticoid-Induced Hyperglycaemia in Renal Disease: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Zeng Wang; Yi Qian Qu; Yang Zhang; Xing Yu Zhu; Xiao Wei Gong; Hong Yu Chen
Journal:  Comput Math Methods Med       Date:  2022-03-07       Impact factor: 2.238

2.  Renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis.

Authors:  Di Wu; Jiuxu Bai; Shaoyuan Cui; Bo Fu; Zhiwei Yin; Guangyan Cai; Xiangmei Chen
Journal:  Ann Transl Med       Date:  2020-03

3.  Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls.

Authors:  Xue Zhou; Ning Wang; Yuefeng Zhang; Pei Yu
Journal:  Front Physiol       Date:  2022-04-07       Impact factor: 4.566

4.  Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy.

Authors:  Tingyu Chen; Eryu Xia; Tiange Chen; Caihong Zeng; Shaoshan Liang; Feng Xu; Yong Qin; Xiang Li; Yuan Zhang; Dandan Liang; Guotong Xie; Zhihong Liu
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.